Community-based organizations and PrEP implementers now have two more resources to help HIV prevention ambassadors promote the meaningful engagement of communities and potential and current PrEP users in the rollout of oral PrEP for HIV prevention: the HIV Prevention Ambassador Training Package and Toolkit, developed by the OPTIONS Consortium and the CHOICE activity of the EpiC and RISE projects.
Adolescents, youth, and young people
Blog
February 15, 2021
Resource
November 25, 2020
A study comparing the characteristics and outcomes of adolescents living with perinatally acquired HIV (ALPH) Using data from 15 International epidemiology Databases to Evaluate AIDS in Southern Africa sites.
News
November 9, 2020
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.
Resource
September 1, 2020
Introduction
Event
July 30, 2020
The webinar focuses on how adolescents living with HIV/AIDS are being impacted by COVID-19. This is based on Priscilla's PhD work and projects she has worked on with the IeDEA team on adolescents living with HIV transitioning to adulthood.
Resource
July 14, 2020
Introduction
Resource
July 1, 2020
The National Strategic Plan for HIV, TB and STIs (NSP) 2017-2022 Mid Term Review (MTR) was an in-depth analysis of the NSP implementation, with the aim to illustrate progress made towards reaching the NSP targets across the eight NSP goals.
News
June 23, 2020
Under level 5 and 4 of South Africa’s COVID-19 lockdown regulations adolescent girls and young women (AGYW) aged 14 to 24 years could not meet face-to-face in specially created safe spaces with counsellors, as part of a combination HIV intervention programme.
News
June 12, 2020
A pivotal clinical trial to address a long-standing question about the relationship between hormonal contraceptive use and the risk of HIV acquisition has found no substantial difference in HIV risk among 7,829 African women who were randomly assigned to use one of three highly effective methods
Resource
June 10, 2020
According to the recent Evidence for Contraceptive Options and HIV Outcomes Study (ECHO) (Box 1) (1), the incidence of HIV infection and other sexually transmitted infections (STIs) remains high among adolescent girls and women in parts of East and Southern Africa.
